Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  New England Journal of Medicine

• Publication date

  1998-07-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199807233390404PMID 9673301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Diabetes on Mortality After the First Myocardial Infarction

  1998cited by this paper
• Management of dyslipidemia in adults with diabetes. American Diabetes Association.

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM

  1997cited by this paper
• The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease

  1997cited by this paper
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

  1997cited by this paper
• Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris. A 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?

  1995cited by this paper
• Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction.

  1992cited by this paper
• Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.

  1990cited by this paper
• Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

  1989cited by this paper
• Atherosclerotic Vascular Disease and Its Risk Factors in Non-Insulin-Dependent Diabetic and Nondiabetic Subjects in Finland

  1988cited by this paper
• The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

  1988cited by this paper
• Diabetes and atherosclerosis: an epidemiologic view.

  1987cited by this paper
• The National Survey of Stroke. Clinical findings.

  1981cited by this paper
• Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

  1979cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper

• Myocardial infarction, stroke, and death after intravitreal injection of anti-vascular endothelial growth factor in a nationwide study

  2026cites this paper
• Trends, variation, and predictors of coronary angiography in potential cardiac organ donors.

  2026cites this paper
• D.R.E.A.M: diabetes risk via explainable AI modeling

  2026cites this paper
• Developmental origins of immunometabolic health

  2026cites this paper
• Treatment-related progression of subclinical atherosclerosis in latent autoimmune diabetes in adults: A two-year longitudinal study.

  2026cites this paper
• Elevated ANGPTL8 (Angiopoietin-Like Protein 8) Levels as a Novel Predictor of Atherosclerosis in Type 2 Diabetes: Beyond Lipid Metabolism.

  2026cites this paper
• Incidence of acute myocardial infarction in people with diabetes compared to those without diabetes: a systematic review.

  2026cites this paper
• In-Hospital mortality and determinants among myocardial infarction patients in public hospitals, Northwest Ethiopia: evidence from sub-Saharan Africa

  2026cites this paper
• SUN-625 Valsartan Induced Severe Hypoglycemia in a Non-diabetic Patient

  2025cites this paper
• Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis

  2025cites this paper
• Incremental Prognostic Value of Perivascular Fat Attenuation Index in Patients with Diabetes with Coronary Artery Disease.

  2025cites this paper
• Diabetes and ischemia in stress perfusion cardiac magnetic resonance are comparable risk factors for cardiovascular events.

  2025cites this paper
• A Systematic Review of Thiamine Supplementation in Improving Diabetes and Its Related Cardiovascular Dysfunction

  2025cites this paper
• Involvement of Nuclear Receptors PPAR-α, PPAR-γ, and the Transcription Factor Nrf2 in Cellular Protection Against Oxidative Stress Regulated by H2S and Induced by Hypoxia–Reoxygenation and High Glucose in Primary Cardiomyocyte Cultures

  2025cites this paper
• Increased high-risk plaque burden in type 2 diabetes: a 10-year follow-up study

  2025cites this paper
• Global impact of PM2.5 on cardiovascular disease: Causal evidence and health inequities across region from 1990 to 2021.

  2025cites this paper
• Association between normal systolic blood pressure maintenance and the risk of coronary artery calcification progression in asymptomatic non-diabetic and diabetic adults: a retrospective cohort study using data from the Korea initiatives on coronary artery calcification registry

  2025cites this paper
• Prognostic implications of quantified coronary atherosclerosis and myocardial perfusion in diabetes

  2025cites this paper
• Patterns among factors associated with myocardial infarction: chi-squared automatic interaction detection tree and binary logit model

  2025cites this paper
• Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?

  2025cites this paper
• Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Diabetes in Peripheral Artery Disease: Prevalence, Complications, and Polypharmacy

  2025cites this paper
• Chronic Coronary Artery Disease.

  2025cites this paper
• Principal components of type 2 diabetes risk: an exploratory factor analysis in an Iranian cohort

  2025cites this paper
• The long-term prognostic value of CT coronary artery calcium score in asymptomatic patients with type 2 diabetes

  2025cites this paper
• Association between the Atherosclerotic Modifiable Risk Factor Burden and Coronary Inflammation.

  2025cites this paper
• Come to the dark side – A review on the health-beneficial and disease-alleviating effects of cocoa-rich dark chocolate

  2025cites this paper
• Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia.

  2025cites this paper
• Micro and Macrovascular Complications in Diabetes Mellitus

  2025cites this paper
• Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know?

  2025cites this paper
• Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes.

  2025cites this paper
• Invasive coronary physiology assessment and predictors of coronary microvascular dysfunction in patients with diabetes mellitus.

  2025cites this paper
• Targeting Ferroptosis With Natural Products to Treat Diabetes and Its Complications: Opportunities and Challenges

  2025cites this paper
• Regional and demographic variations in diabetes mellitus and myocardial infarction mortality among US adults: A retrospective observational analysis from 1999 to 2023

  2025cites this paper
• Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study

  2025cites this paper
• Comparison of Cardiac Events and Survival Between Asymptomatic Diabetic and Nondiabetic Patients: Coronary CT Study

  2025cites this paper
• Factors Related to Suboptimal Adherence to Dyslipidemia Medication: An Exploration Using Nationally Representative Databases

  2025cites this paper
• Purified C. pilosula polysaccharides attenuate streptozotocin-induced oxidative stress and restore gut microbiota in T2DM mice.

  2025cites this paper
• Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial

  2025cites this paper
• Applications of AI in the management of elderly diabetes patients.

  2025cites this paper
• Risk Stratification and Coronary Optical Coherence Tomography Findings in Asymptomatic Patients With Type 1 Diabetes Mellitus

  2025cites this paper
• New sights of tumor-specific growth factor (TSGF) in T2DM patients with coronary artery disease

  2025cites this paper
• Cardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors

  2025cites this paper
• Emergency Left Ventricular AssistImplantation for a Refractory Ischemic Cardiomyopathy with Drug-Resistant Bacterial Infection

  2025cites this paper
• Complications cardiaques du patient diabétique (maladie coronaire, cardiomyopathie, neuropathie autonome cardiovasculaire) : dépistage

  2025cites this paper
• La resonancia magnética cardíaca de estrés como fuerte predictor de eventos cardiovasculares en población diabética

  2025cites this paper
• Vascular endothelial cell injury: causes, molecular mechanisms, and treatments

  2025cites this paper
• Adding Lemon and n-3 PUFA-Rich Oil to Tomato Juice Preload to a Carbohydrate Meal Ameliorates Early Glycemic and Insulin Responses in Young Healthy Women: A Randomized Crossover Trial.

  2025cites this paper
• Presence of coronary artery disease in adults with newly detected diabetes mellitus

  2025cites this paper
• Multiple long-term conditions as the next transition in the global diabetes epidemic

  2025cites this paper
• Independent Prognostic Significance of Myocardial Flow Reserve over Coronary Artery Calcium, Myocardial Perfusion, and Clinical Variables in Patients without Known CAD, according to Diabetes Status.

  2025cites this paper
• Exploratory Analysis of Serum Oxidized Albumin as a Potential Prognostic Indicator for Diabetic Microvascular Complications: A Retrospective Cohort Pilot Study

  2025cites this paper
• The different effects of admission blood glucose levels on the outcomes of ST elevation myocardial infarction patients with and without diabetes

  2025cites this paper
• Prevalence of isolated nocturnal hypertension among patients with type 2 diabetes mellitus.

  2025cites this paper
• Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications

  2025cites this paper
• Integrated meta-analysis and network pharmacology analysis: evaluation of Zhigancao decoction as treatment for diabetic cardiomyopathy

  2025cites this paper
• Association between bone mineral density and vascular health in rheumatoid arthritis

  2025cites this paper
• Transit time flow management as a management strategy in high-risk groups undergoing coronary artery bypass grafting

  2025cites this paper
• Mechanistic underpinnings of AGEs-RAGE via DIAPH1 in ischemic, diabetic, and failing hearts.

  2025cites this paper
• Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications

  2025cites this paper
• Comparative Analysis of Pattern of Symptoms of Chest Pain in Patients with and without Diabetes: A Systematic Review

  2025cites this paper
• Advances in Metabolomics: A Comprehensive Review of Type 2 Diabetes and Cardiovascular Disease Interactions

  2025cites this paper
• Development of a Novel Machine Learning Method for Estimation of Life‐Long Chronic Disease Progression and Its Application to Type 2 Diabetes

  2025cites this paper
• Soluble receptor for advanced glycation end products and its role in cardiovascular risk assessment in hyperglycemia – A study in North India

  2025cites this paper
• The effect of diabetes on plaque, stenosis, and coronary artery calcium score.

  2025cites this paper
• Pancreatic β-cell Dysfunction and Diabetes

  2025cites this paper
• Pedalling towards better health: a randomised controlled trial of aerobic cycling to improve glycaemic control and quality of life in middle-aged men with type 2 diabetes

  2025cites this paper
• 7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction

  2025cites this paper
• Effects of High Glucose on Simulated Ischemia/Reperfusion Injury in Isolated Cardiomyocytes

  2025cites this paper
• 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

  2025cites this paper
• Machine learning and SHAP value interpretation for predicting cardiovascular disease risk in patients with diabetes using dietary antioxidants

  2025cites this paper
• Cardiovascular outcomes of patients with type 2 diabetes after myocardial infarction and the impact of diabetes duration: a nationwide registry study.

  2025cites this paper
• The association of bone mineral density with cardiovascular disease and mortality among individuals with/without type 2 diabetes: a population-based retrospective cohort

  2025cites this paper
• Artificial intelligence algorithm for predicting cardio-cerebrovascular risk in type 2 diabetes: concordance with clinical and instrumental assessments

  2025cites this paper
• Acute ST-Segment Elevation Myocardial Infarction in a 19-Year-Old Due to Uncontrolled Diabetes

  2025cites this paper
• HDL metabolism and function in diabetes mellitus

  2025cites this paper
• Association of KCNJ11 rs5219 polymorphism with risk of type 2 diabetes and its cardiovascular and renal complications in Noakhali, Bangladesh

  2025cites this paper
• Development and Validation of Novel Residual Risk Scores for Patients With ASCVD

  2025cites this paper
• Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.

  2024cites this paper
• The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study

  2024cites this paper
• Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus

  2024cites this paper
• Assessment of atherogenic indices and modification of lipid profiles by aqueous and methanol extracts of Terminalia catappa leaves in diabetic rats

  2024cites this paper
• Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights

  2024cites this paper
• Modeling Foam Cell Formation in A Hydrogel‐Based 3D‐Intimal Model: A Study of The Role of Multi‐Diseases During Early Atherosclerosis

  2024cites this paper
• Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology

  2024cites this paper
• Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis.

  2024cites this paper
• Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review

  2024cites this paper
• Prévention primaire de la maladie athéromateuse – un objectif prioritaire : dépister le haut risque cardiovasculaire

  2024cites this paper
• COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type

  2024cites this paper
• United States Pooled Cohort Cardiovascular Disease Risk Scores in Adults With Diabetes Mellitus

  2024cites this paper
• Diabetes and cardiovascular disease in older adults

  2024cites this paper
• Type 2 diabetes and chronic kidney disease as long‐term predictors of cardiovascular events in patients with coronary artery disease

  2024cites this paper
• Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Acute Coronary Syndrome and Type 2 Diabetes

  2024cites this paper
• Uncover visit-to-visit blood pressure variability as the hidden risk factor/predictor for coronary artery disease, stroke and malignant tumor in patients with type 2 diabetes

  2024cites this paper
• The effect of repeated hot water immersion on vascular function, blood pressure and central haemodynamics in individuals with type 2 diabetes mellitus.

  2024cites this paper
• Comparison of adverse cardiovascular event endpoints between patients with diabetes and patients without diabetes based on coronary artery plaques: a systematic review and meta-analysis

  2024cites this paper
• Development and validation of an interpretable machine learning model associated with erythrocyte fatty acids to identify coronary artery disease among Chinese adults

  2024cites this paper
• Serum lipid peroxidation potential as a biomarker for risk-stratification of coronary artery disease in patients with type 2 diabetes mellitus.

  2024cites this paper
• Plant-Based Diets and Phytochemicals in the Management of Diabetes Mellitus and Prevention of Its Complications: A Review

  2024cites this paper
• Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database

  2024cites this paper